Lin Judith C
Division of Vascular Surgery, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, Michigan, USA.
Ann Vasc Surg. 2013 Oct;27(7):976-83. doi: 10.1016/j.avsg.2013.02.004. Epub 2013 Jul 10.
The evolution of minimally invasive treatment for aneurysms and occlusive disease has led to the development of endovascular, laparoscopic, and robot-assisted techniques. This article reviews the current literature on the clinical use of robotic surgical systems in the treatment of patients with aneurysms and occlusive disease.
A MEDLINE search was performed using the keywords "robotic, vascular, AND surgery." All pertinent articles concerning the use of the robotic surgical system on aneurysms and occlusive disease were reviewed. The author's personal experience consisted of a retrospective review of a prospectively maintained confidential database on all procedures performed with the da Vinci(®) surgical system.
Several robot-assisted laparoscopic series on the treatment of aortic disease were identified, including review articles of potential clinical applications in hybrid, laparoscopic vascular, and endovascular treatments for vascular patients using robotic technology. The use of computer-enhanced or robotic technology as a sole modality for bypass of occlusive disease and repair of abdominal aortic, splenic, and renal aneurysms was described in case series with satisfactory patient outcomes. Current robotic endovascular technology was also described.
Minimally invasive techniques using endovascular, laparoscopic, or robot-assisted technology have revolutionized the treatment of aortoiliac, splanchnic, and renal aneurysms and occlusive disease. However, robot-assisted techniques for aortic disease may involve a learning curve and increased operating times. Although endovascular therapy is preferred because of faster recovery, this preference for improved short-term outcomes will be balanced with the superiority and durability of robot-assisted endoscopic methods as comparable to open surgery.
动脉瘤和闭塞性疾病的微创治疗进展催生了血管内、腹腔镜及机器人辅助技术的发展。本文回顾了关于机器人手术系统在动脉瘤和闭塞性疾病患者治疗中临床应用的当前文献。
使用关键词“机器人、血管、手术”进行MEDLINE检索。对所有关于机器人手术系统用于动脉瘤和闭塞性疾病的相关文章进行了综述。作者的个人经验包括对一个前瞻性维护的关于所有使用达芬奇(®)手术系统进行的手术的保密数据库进行回顾性分析。
确定了几篇关于机器人辅助腹腔镜治疗主动脉疾病的系列报道,包括使用机器人技术在血管疾病患者的杂交、腹腔镜血管及血管内治疗中的潜在临床应用的综述文章。在病例系列报道中描述了使用计算机增强或机器人技术作为治疗闭塞性疾病及修复腹主动脉瘤、脾动脉瘤和肾动脉瘤的唯一方式,患者预后良好。还介绍了当前的机器人血管内技术。
使用血管内、腹腔镜或机器人辅助技术的微创技术彻底改变了主髂动脉、内脏和肾动脉瘤及闭塞性疾病的治疗方式。然而,机器人辅助治疗主动脉疾病可能存在学习曲线且手术时间会延长。尽管由于恢复更快而更倾向于血管内治疗,但这种对改善短期预后的偏好将与机器人辅助内镜方法与开放手术相当的优越性和耐久性相平衡。